Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2534

Related search